Javier Vázquez-Bourgon at University of Cantabria - Research Interests, Publications & Academic Profile

Javier Vázquez-Bourgon

Assistant Professor of Psychiatry

Universidad de Cantabria

Spain

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Chinese students reach out?

Meet Kite AI

Contact this professor

Send an email LinkedIn ORCID

Google Scholar

Research Interests

Psychiatry

90%

Neuropsychology

40%

Psychoneuroimmunology

40%

Mental Illness

40%

Psychosis

40%

Neuropharmacology

30%

Polypharmacy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

The role of dopaMINE in bRain-liVer Axis in psychosis patients developing non-alcoholic fatty lIver diseae. The MINERVA study.

Open Date: 2021-01-01

Close Date: 2023-01-01

Grant: Close

Tratamiento estratificado en esquizofrenia: Integrando resultados de transcriptoma humano y celular en las estrategias de Tratamiento antipsicótico.

Open Date: 2019-04-01

Close Date: 2021-06-01

Articles11

Cross-sectional and longitudinal assessment of the association between DDR1 variants and processing speed in patients with early psychosis and healthy controls

Article Link

Year:

2023

Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study

Article Link

Year:

2023

Intelligence quotient changes over 10 years: Diversity of cognitive profiles in first episode of psychosis and healthy controls.

Article Link

Year:

2023

Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis.

Article Link

Year:

2023

Long-term mental health impact of COVID-19 on Primary Care health workers in northern Spain; results from a two-phase longitudinal study.

Article Link

Year:

2023

Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort

Article Link

Year:

2023

Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis

Article Link

Year:

2022

Obesity and brain structure in schizophrenia - ENIGMA study in 3021 individuals.

Article Link

Year:

2022

Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial

Article Link

Year:

2022

Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis

Article Link

Year:

2022

Naturalistic study on the use of clozapine in the early phases of non-affective psychosis: A 10-year follow-up study in the PAFIP-10 cohort

Article Link

Year:

2022

Collaborators15

Antonio Pardiñas

Lecturer

Cardiff University

UNITED KINGDOM

Antonin Skoch

Institute of Experimental Medicine

CZECH REPUBLIC

Gary Donohoe

Professor & chair of Psychology

National University of Ireland Galway

IRELAND

Karl David Neergaard

Research Professor

Tecnológico de Monterrey

SPAIN

James MacCabe

King’s College London

UNITED KINGDOM

Jorge Moya-Higueras

Associate professor

University of Lleida

SPAIN

Udo Dannlowski

University of Münster

GERMANY

Sean R. McWhinney

Dalhousie University

CANADA

Lourdes Martorell

Assistant professor

Universitat Rovira i Virgili

SPAIN

Thomas Weickert

Associate Professor

SUNY Upstate Medical University

UNITED STATES

vanessa sanchez-gistau

Associate professor

Universitat Rovira i Virgili

SPAIN

Sophie Smart

King’s College London

UNITED KINGDOM

Nancy Murillo-García

Instituto de Investigación Marqués de Valdecilla

SPAIN

Benedicto Crespo-Facorro

SPAIN

paolo brambilla

Associate Professor of Psychiatry

ITALY

How do Chinese students reach out?

Meet Kite AI